moxaverine

Known as: 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline 
 

Topic mentions per year

Topic mentions per year

1987-2016
0119872016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
PURPOSE The phosphodiesterase inhibitor moxaverine has been shown to increase choroidal blood flow (BF) in young healthy subjects… (More)
Is this relevant?
2012
2012
To investigate the effect of orally administered moxaverine (Kollateral forte®) on ocular blood flow in young healthy subjects… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2011
2011
Background Reduced ocular perfusion is related to several common eye diseases, like age-related macular degeneration, diabetic… (More)
Is this relevant?
2009
2009
PURPOSE A number of common eye diseases are associated with ocular perfusion abnormalities. The present study aimed to… (More)
Is this relevant?
1993
1993
A reversed-phase ion-pair high-performance liquid chromatographic separation was developed for identification and quantitation of… (More)
Is this relevant?
1989
1989
Immediately after undergoing emergency mitral valve replacement, a 60-year-old woman suffered acute postoperative right heart… (More)
Is this relevant?
1988
1988
Vasodilator properties of papaverine and moxaverine have been attributed to an inhibition of cyclic adenosine monophosphate (c… (More)
Is this relevant?
1988
1988
Using a combination of novel techniques to assess quantitatively the shape and the filterability of red blood cells (RBC) after… (More)
Is this relevant?
1988
1988
Using a computer assisted filtration system, 6 drugs (bencyclane, moxaverine, naftidrofuryl, pentoxyfylline, vincamine… (More)
Is this relevant?
1987
1987
The phosphodiesterase (PDE)-inhibiting and smooth muscle relaxing effects of theophylline, enprofylline, papaverine and… (More)
Is this relevant?